drugset / Trial / NCT02479139
Clinical Trial To Evaluate ANT-1207 In Participants With Primary Axillary Hyperhidrosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to establish the therapeutic range of ANT-1207 in the treatment of primary axillary hyperhidrosis.
Timeline
- Start
- 2015-06-03
- Primary completion
- 2016-02-29
- Completion
- 2016-02-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | — | Topical |